+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Melanoma Drugs Market Report 2025 - Product Thumbnail Image

Melanoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Metastatic Melanoma Therapeutics Market Report 2025 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non Hodgkin Lymphoma (NHL) Market Report 2025 - Product Thumbnail Image

Non Hodgkin Lymphoma (NHL) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Follicular Lymphoma Treatment Market Report 2025 - Product Thumbnail Image

Follicular Lymphoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cystic Fibrosis (CF) Therapy Area Report - Product Thumbnail Image

Cystic Fibrosis (CF) Therapy Area Report

  • Report
  • November 2021
  • 51 Pages
  • Global
From
Hairy Cell Leukemia - Global Strategic Business Report - Product Thumbnail Image

Hairy Cell Leukemia - Global Strategic Business Report

  • Report
  • July 2025
  • 273 Pages
  • Global
From
Pollen Allergy - Global Strategic Business Report - Product Thumbnail Image

Pollen Allergy - Global Strategic Business Report

  • Report
  • July 2025
  • 498 Pages
  • Global
From
Basal Cell Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Basal Cell Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
From
Marginal Zone Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Marginal Zone Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Loading Indicator